GlassScriptPhysician profile
Stephen Brigido
NPI 1407853336
$655,954.27
in general payments reported to CMS, 2019-2025
9 companies · $13K in 2025
The $13K reported for 2025 was more than what 97% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145K · 2020: $36K · 2021: $13K · 2022: $71K · 2023: $351K · 2024: $26K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $336K · Royalty Or License: $34K · Travel and Lodging: $17K · Food and Beverage: $2,712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $336,000.00 |
| Royalty Or License | $34,130.33 |
| Travel and Lodging | $17,314.55 |
| Food and Beverage | $2,711.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $519,794.86 | 2019-2025 | Ortholoc 2 Lapifuse, Hoffmann, Prostep |
| Celularity INC. | $42,881.00 | 2019 | |
| Linvatec Corporation | $34,130.33 | 2023-2025 | In2bones USA, Quantum, Triway |
| In2bones USA, LLC | $30,904.83 | 2019-2022 | |
| Integra Lifesciences Corporation | $27,984.43 | 2019-2020 | |
| Sanara Medtech INC. | $138.99 | 2023 | Celleraterx |
| Arthrex, INC. | $75.00 | 2021 | |
| Smith+Nephew, INC. | $22.52 | 2023 | Memofix Super Elastic Nitinol Staple System |
| 4web, INC. | $22.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Brigido listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.